Pi Therapeutics' Other Investors

Pi Therapeutics raised a round of funding on , . Investors include Pontifax.

Pi Therapeutics is developing inhibitors for a novel target in the ubiquitin proteasome system, a pathway utilized by cancer cells for their growth and survival.…

Articles about Pi Therapeutics' Other Investors: